PMC:7796052 / 7749-7919 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"233","span":{"begin":149,"end":160},"obj":"Gene"},{"id":"234","span":{"begin":122,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"Gene:624"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"MESH:D020849"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ic profile of the compound can be rationalized from docking studies. Figure 2 shows the prospective bound conformation of raloxifene (orange) to the B2 receptor, superimp"}